Navigation Links
Foam injections for varicose veins better for patients and cheaper, study finds
Date:9/25/2011

Under embargo until 9am UK time Sunday 25 September 2011

Foam injections to treat varicose veins cause less pain for patients and could save NHS money compared with a popular alternative treatment, according to researchers at Imperial College London. The study found that foam therapy was over four times more cost-effective than laser treatment and allowed patients to resume normal activity sooner. The findings were presented today at the annual meeting of the European Vascular Society in Athens.

Varicose veins develop when the valves in veins stop working properly, causing the veins to swell. About one in three people have varicose veins when they reach retiring age, with women affected more than men. In most people, they do not present a serious health problem, but in severe cases they can cause aching, itching, swelling or leg ulcers.

Patients requiring treatment often undergo surgery to strip out the affected vein. Under general anaesthetic, the vein is tied off through a cut in the groin and pulled out by a wire passed through a cut lower in the leg. 36,209 varicose vein procedures are carried out in the NHS each year.

In the last decade, new non-surgical treatments have been introduced that cause less scarring and do not require general anaesthetic. Endovenous Laser Ablation (EVLA) involves a laser wire, inserted into the vein through a catheter, which delivers short bursts of energy that seal the vein closed. It is usually carried out under local anaesthetic. Foam sclerotherapy involves injecting foam into the vein that inflames the lining of the wall and seals the vessel.

The new study compared these two treatments in terms of benefit to the patient and cost. One hundred patients were randomly assigned to laser or foam treatment. The two treatments were found to be equally successful at closing off varicose veins. However, foam therapy procedures were more than twice as quick and cost over four times less than laser treatment on average. Patients who had foam therapy experienced less pain in the week following treatment and could return to normal activity in three days, compared with eight days for patients who had laser therapy.

Mr Christopher Lattimer, from the Department of Surgery and Cancer at Imperial College London, said: "This is the first time that anyone in the NHS has compared foam and laser treatments to see which is better value for money. We found that foam was 4.2 times cheaper, taking into account their effectiveness. Foam treatment was also quicker, less painful, and had people back to normal activity in a shorter time."

Mr George Geroulakos, from the Department of Surgery and Cancer at Imperial College London, said: "Because varicose veins are so common, the NHS has to spend a lot of money on treatments each year. If more people are treated with foam injections instead of surgery or laser treatment, the potential savings could be enormous. This sort of research is hugely important at a time when budgets are under such strain."

The number of patients receiving these treatments is increasing each year, with the NHS performing 6,327 foam procedures and 6,005 EVLA procedures in England in 2009-10.

Closing the veins that run near the skin does not impair circulation as blood can still return to the heart through the larger veins inside the leg.


'/>"/>

Contact: Sam Wong
samwong87@gmail.com
44-207-594-2198
Imperial College London
Source:Eurekalert

Related medicine news :

1. Heart damage improves, reverses after stem cell injections in a preliminary human trial
2. New Drug May Trim Insulin Injections to Just 3 a Week
3. Warming Injections May Take Out the Sting
4. Insulin Pump With Blood Sugar Sensor May Improve on Injections
5. Tiger Takes Another Shot: PRP Injections Put On the Spot
6. X-ray guided steroid injections effectively treat hamstring tendonitis, study suggests
7. Botox Injections May Relieve Tennis Elbow Pain
8. FDA Issues Warning on Fat-Melting Spa Injections
9. Two Varicose Veins Treatments Equally Effective
10. Varicose vein study shows radiofrequency ablation causes less post-operative pain
11. AngioDynamics' VenaCure EVLTTM System for Varicose Veins To Be Featured On 'The Doctors' National Television Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... Richmond, BC (PRWEB) , ... April 25, 2017 , ... ... patients from Richmond, BC, who live with dental fear and require sedation to receive ... anxiety at ease during various procedures, from hygienic cleanings to oral surgery, at ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... they rely on contracted partners to help with process innovation in drug formulation ... drug formulation experience along with state-of-the-art analytical equipment in support of their development ...
(Date:4/25/2017)... MN (PRWEB) , ... April 25, 2017 , ... Buyers ... and recreational users to dispensaries and head shops –can’t help but be heartened by ... for the tell-tale cannabis odor aptly described as “skunk smell.” At last they ...
(Date:4/25/2017)... ... 25, 2017 , ... Emergency Physician and Distinguished Professor of Emergency Medicine Bentley ... in Writing, set to publish in summer 2017. , Dr. Bobrow, MD, FACEP, ... Arizona College of Medicine. He also serves as Medical Director for the Bureau of ...
(Date:4/25/2017)... ... April 25, 2017 , ... Amendia, Inc., designer, developer, and ... partnership with and platinum sponsorship of Global Spine Outreach (“GSO”), a charitable organization ... of complex spine deformity cases, particularly in children. , GSO’s focus is to ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... April 19, 2017 Global Surgical Drainage Device ... tubes used to remove excess liquid and air. The ... urine, bile or lymph. Surgical drains are used in ... as orthopedics surgery, cardiovascular surgery, neurosurgery, plastic surgery etc. ... to prevent accumulation of fluid e.g. blood or pus. ...
(Date:4/19/2017)... 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... company developing new treatments for cancer and other ... its previously announced underwritten public offering of 23,625,084 ... offering price of $2.00 per share, before deducting ... payable by Sorrento.  The net proceeds to Sorrento ...
(Date:4/19/2017)... , April 19, 2017  SARES•REGIS Group ... it is developing at Conejo Spectrum Business Park ... to Atara Biotherapeutics, Inc. , a biopharmaceutical ... and life-threatening diseases that have been underserved by ... T-cell therapies for cancer, autoimmune and infectious disease. ...
Breaking Medicine Technology: